155 related articles for article (PubMed ID: 23101617)
1. A missing link in genotype-directed cancer therapy.
Bernards R
Cell; 2012 Oct; 151(3):465-8. PubMed ID: 23101617
[TBL] [Abstract][Full Text] [Related]
2. Epistatic interactions and drug response.
Weigelt B; Reis-Filho JS
J Pathol; 2014 Jan; 232(2):255-63. PubMed ID: 24105606
[TBL] [Abstract][Full Text] [Related]
3. Progress towards personalized medicine.
Bates S
Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy: overcoming drug resistance with clinical cancer genome.
Ziogas DE; Katsios CS; Tzaphlidou M; Roukos DH
Expert Rev Anticancer Ther; 2012 Jul; 12(7):861-4. PubMed ID: 22845399
[No Abstract] [Full Text] [Related]
5. The search for optimal response prediction in cancer leads to a personalized approach.
Van Cutsem E; Ciardiello F
Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
[No Abstract] [Full Text] [Related]
6. Preface: National Cancer Act.
Smalley KS
Adv Pharmacol; 2012; 65():xi-xiii. PubMed ID: 22959037
[No Abstract] [Full Text] [Related]
7. Prospects for personalized medicine with inhibitors targeting the RAS and PI3K pathways.
Lackner MR
Expert Rev Mol Diagn; 2010 Jan; 10(1):75-87. PubMed ID: 20014924
[TBL] [Abstract][Full Text] [Related]
8. From cancer genomics to precision oncology--tissue's still an issue.
Cohen RL; Settleman J
Cell; 2014 Jun; 157(7):1509-14. PubMed ID: 24949964
[TBL] [Abstract][Full Text] [Related]
9. Cancer research. Looking for a target on every tumor.
Kaiser J
Science; 2009 Oct; 326(5950):218-20. PubMed ID: 19815749
[No Abstract] [Full Text] [Related]
10. The era of cancer discovery.
Cantley LC; Baselga J
Cancer Discov; 2011 Jun; 1(1):1. PubMed ID: 22586302
[No Abstract] [Full Text] [Related]
11. Cancer robustness: tumour tactics.
Kitano H
Nature; 2003 Nov; 426(6963):125. PubMed ID: 14614483
[No Abstract] [Full Text] [Related]
12. [Value of inhibition of signal transduction and epigenetic therapy concepts in cancer therapy].
Tabernero J; Kaye S
Onkologie; 2005 Oct; 28 Suppl 4():43-7. PubMed ID: 16285040
[No Abstract] [Full Text] [Related]
13. Impact of genomics on personalized cancer medicine.
Arteaga CL; Baselga J
Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
[TBL] [Abstract][Full Text] [Related]
14. The Hedgehog pathway as a drug target in cancer therapy.
Lauth M; Toftgård R
Curr Opin Investig Drugs; 2007 Jun; 8(6):457-61. PubMed ID: 17621875
[TBL] [Abstract][Full Text] [Related]
15. Cancer pharmacogenetics.
Marsh S
Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
[TBL] [Abstract][Full Text] [Related]
16. Cancer cell line encyclopedia will help researchers match drugs to patients in clinical trials.
McBride D
ONS Connect; 2012 Jun; 27(6):21. PubMed ID: 22774345
[No Abstract] [Full Text] [Related]
17. [Targeted drugs a chance for a better cure].
Bergh J; Jonsson B
Lakartidningen; 2010 Apr 21-27; 107(16):1071-4. PubMed ID: 20476704
[No Abstract] [Full Text] [Related]
18. [Individualized cancer therapy and treatment based on syndrome differentiation].
Wang ZY
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):158-60. PubMed ID: 23714675
[No Abstract] [Full Text] [Related]
19. Individualized drug therapy.
Daly AK
Curr Opin Drug Discov Devel; 2007 Jan; 10(1):29-36. PubMed ID: 17265738
[TBL] [Abstract][Full Text] [Related]
20. Cancer Cell Line Encyclopedia launched by Novartis and Broad Institute.
Marum L
Future Med Chem; 2012 May; 4(8):947. PubMed ID: 22826900
[No Abstract] [Full Text] [Related]
[Next] [New Search]